Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
02/01/2000 | US6020478 Human tumor-associated antigen |
02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
02/01/2000 | US6020467 Antibodies against sulfotransferase |
02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
02/01/2000 | US6020461 Detection of gonorrhea is one area in which nucleic acid hybridization holds great potential as a diagnostic tool in clinical medicine. |
02/01/2000 | US6020327 Control of hair growth |
02/01/2000 | US6020312 Synthetic antibiotics |
02/01/2000 | US6020212 Phycobiliprotein-linker peptide complex fluorescent tracer and methods of using the same |
02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
02/01/2000 | US6020165 Cytikine signal regulators |
02/01/2000 | US6020164 Human RNA binding proteins |
02/01/2000 | US6020163 Lipocalin homolog |
02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
02/01/2000 | US6020159 3-dehydroquinate synthase |
02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
02/01/2000 | US6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use |
02/01/2000 | US6020153 Chimeric antibodies |
02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
02/01/2000 | US6020148 In vitro method for eye and skin irritation testing |
02/01/2000 | US6020146 Carcinogenicity testing system |
02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
02/01/2000 | US6020140 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
02/01/2000 | US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
02/01/2000 | US6019969 Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β) |
02/01/2000 | US6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
02/01/2000 | CA2171982C Drug binding protein |
02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
01/27/2000 | WO2000004383A2 Hiv group o positive control |
01/27/2000 | WO2000004183A1 Bone morphogenic protein |
01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
01/27/2000 | WO2000004140A1 71 human secreted proteins |
01/27/2000 | WO2000004137A1 Human aspartic proteases |
01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
01/27/2000 | WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
01/27/2000 | WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
01/27/2000 | WO2000003730A1 Urease based vaccine against helicobacter infection |
01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
01/27/2000 | WO1999061040A3 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
01/27/2000 | WO1999059609A3 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
01/27/2000 | DE19856301C1 Regulatory protein pKe83 from human epidermal keratinocytes and related nucleic acid, vectors and antibodies |
01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
01/27/2000 | CA2337511A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
01/27/2000 | CA2334075A1 Bone morphogenic protein |
01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
01/27/2000 | CA2333917A1 71 human secreted proteins |
01/27/2000 | CA2333910A1 Neurotrophic growth factor |
01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |
01/27/2000 | CA2333467A1 Human presenilin-associated protein |
01/27/2000 | CA2303062A1 Human aspartic proteases |
01/26/2000 | EP0974841A2 Suppression of interference in immunoassays using substances derived from the framework regions of antibodies |
01/26/2000 | EP0974671A1 Method for diagnosing bone dysbolism |
01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
01/26/2000 | EP0974600A2 Anti-interleukin-18 antibody |
01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
01/26/2000 | EP0973933A1 Immunological tolerance to hiv epitopes |
01/26/2000 | EP0973928A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
01/26/2000 | EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING |
01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
01/26/2000 | EP0973897A1 Human tumor-associated membrane protein |
01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
01/26/2000 | EP0973893A1 Intracellular amyloid-beta binding (erab) polypeptide |
01/26/2000 | EP0973892A2 28 human secreted proteins |
01/26/2000 | EP0973891A1 Human chemokine receptor-like chemokine |
01/26/2000 | EP0973888A1 Dendritic cell-derived growth factor |
01/26/2000 | EP0973879A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
01/26/2000 | EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE |
01/26/2000 | EP0973870A1 Methods for selecting germ-line competent cells in chicken embryos, and the use of the cells in the production of chimeras |
01/26/2000 | EP0973867A1 Cell culture media for enhanced protein production |
01/26/2000 | EP0973805A1 Method for production of antibodies to specific sites of rapamycin |
01/26/2000 | EP0973804A2 Anti-vegf antibodies |
01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |